Imunon converts USD 1.2 million debt into newly issued preferred shares

• Imunon exchanged USD 1.2 million of A-1 Note principal, accrued interest for 120 shares of newly designated Series B Preferred Stock.
• Transaction cut outstanding debt by about 43% while increasing stockholders’ equity.
• No common stock issued. No warrants issued. Series B Preferred Stock is non-convertible into common stock.
• Series B priced at USD 10,000 per share with USD 12,000 stated value. Company designated 200 Series B shares.
• Exchange did not provide additional cash proceeds.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Imunon Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202609290800PRIMZONEFULLFEED9835722) on September 29, 2026, and is solely responsible for the information contained therein.